Search Results - "Wiesner, R.H."

Survival in Portopulmonary Hypertension: Mayo Clinic Experience Categorized by Treatment Subgroups by Swanson, K. L., Wiesner, R. H., Nyberg, S. L., Rosen, C. B., Krowka, M. J.

“…To determine the natural history of portopulmonary hypertension (POPH), a retrospective screening‐right heart catheterization‐survival analysis of patients was…”
Get full text

De Novo Sirolimus and Reduced‐Dose Tacrolimus Versus Standard‐Dose Tacrolimus After Liver Transplantation: The 2000–2003 Phase II Prospective Randomized Trial by Asrani, S. K., Wiesner, R. H., Trotter, J. F., Klintmalm, G., Katz, E., Maller, E., Roberts, J., Kneteman, N., Teperman, L., Fung, J. J., Millis, J. M.

“…We studied whether the use of sirolimus with reduced‐dose tacrolimus, as compared to standard‐dose tacrolimus, after liver transplantation is safe, tolerated…”
Get full text

Recurrent Primary Biliary Cirrhosis After Liver Transplantation by Silveira, M. G., Talwalkar, J. A., Lindor, K. D., Wiesner, R. H.

“…Recurrent primary biliary cirrhosis (PBC) is an important clinical outcome after liver transplantation (LT) in selected patients. Prevalence rates for…”
Get full text

Post‐Transplant Lymphoproliferative Disorders Following Liver Transplantation: Incidence, Risk Factors and Survival by Kremers, W. K., Devarbhavi, H. C., Wiesner, R. H., Krom, R. A. F., Macon, W. R., Habermann, T. M.

“…This study investigates retrospectively the incidence, risk factors and mortality of post‐transplant lymphoproliferative disorders (PTLD) in adult orthotopic…”
Get full text

183 RECURRENCE OF PRIMARY SCLEROSING CHOLANGITIS AFTER LIVER TRANSPLANTATION by Singh, S, Talwalkar, J.A, Kim, W.R, Hay, E.J, Poterucha, J.J, Charlton, M.R, Rosen, C.B, Heimbach, J.K, Wiesner, R.H

Get full text

107 INSULIN RESISTANCE, SERUM ADIPOKINES AND THE RISK OF FIBROSIS PROGRESSION IN PATIENTS TRANSPLANTED FOR HEPATITIS C: A PROSPECTIVE COHORT STUDY by Veldt, B.J, Poterucha, J.J, Watt, K.D.S, Wiesner, R.H, Hay, J.E, Rosen, C.B, Heimbach, J.K, Janssen, H.L.A, Charlton, M.R

Get full text

Combined Liver Transplantation and Gastric Sleeve Resection for Patients With Medically Complicated Obesity and End‐Stage Liver Disease by Heimbach, J. K., Watt, K. D. S., Poterucha, J. J., Ziller, N. Francisco, Cecco, S. D., Charlton, M. R., Hay, J. E., Wiesner, R. H., Sanchez, W., Rosen, C. B., Swain, J. M.

“…Obesity is increasingly common before and after liver transplantation (LT), yet optimal management remains unclear. Our aim was to analyze the effectiveness of…”
Get full text

Insulin Resistance, Serum Adipokines and Risk of Fibrosis Progression in Patients Transplanted for Hepatitis C by Veldt, B. J., Poterucha, J. J., Watt, K. D. S., Wiesner, R. H., Hay, J. E., Rosen, C. B., Heimbach, J. K., Janssen, H. L. A., Charlton, M. R.

“…In the nontransplant setting diabetes mellitus is a risk factor for disease progression in patients with chronic hepatitis C virus (HCV) infection. The impact…”
Get full text

Impact of Pegylated Interferon and Ribavirin Treatment on Graft Survival in Liver Transplant Patients with Recurrent Hepatitis C Infection by Veldt, B. J., Poterucha, J. J., Watt, K. D. S., Wiesner, R. H., Hay, J. E., Kremers, W. K., Rosen, C. B., Heimbach, J. K., Charlton, M. R.

“…Recurrent hepatitis C virus (HCV) infection is a major cause of morbidity and mortality after liver transplantation for HCV‐related end stage liver disease…”
Get full text

Transplant Center Quality Assessment Using a Continuously Updatable, Risk‐Adjusted Technique (CUSUM) by Axelrod, D. A., Guidinger, M. K., Metzger, R. A., Wiesner, R. H., Webb, R. L., Merion, R. M.

“…Access to timely, risk‐adjusted measures of transplant center outcomes is crucial for program quality improvement. The cumulative summation technique (CUSUM)…”
Get full text

Reduced Priority MELD Score for Hepatocellular Carcinoma Does Not Adversely Impact Candidate Survival Awaiting Liver Transplantation by Sharma, P., Harper, A. M., Hernandez, J. L., Heffron, T., Mulligan, D. C., Wiesner, R. H., Balan, V.

“…The liver organ allocation policy of the United Network for Organ Sharing (UNOS) is based on the model for end‐stage liver disease (MELD). The policy provides…”
Get full text

Mycophenolate Mofetil Use Is Associated with Decreased Risk of Late Acute Rejection in Adult Liver Transplant Recipients by Wiesner, R. H., Steffen, B. J., David, K. M., Chu, A. H., Gordon, R. D., Lake, J. R.

“…Mycophenolate mofetil (MMF) used in a triple‐drug regimen has been shown to decrease acute rejection rates, compared to a double‐drug regimen. The impact of…”
Get full text

Addition of MMF to Dual Immunosuppression Does Not Increase the Risk of Malignant Short‐Term Death After Liver Transplantation by Lake, J.R., David, K.M., Steffen, B.J., Chu, A.H., Gordon, R.D., Wiesner, R.H.

“…Immunosuppression is often incriminated for the increased risk of post‐transplant malignancies. To examine whether triple‐ (MMF+Tacro+CS) versus dual‐drug…”
Get full text

Factor XII Deficiency Acquired by Orthotopic Liver Transplantation: Case Report and Review of the Literature by Osborn, N. K., Ustundag, Y., Zent, C. S., Wiesner, R. H., Rosen, C. B., Narayanan Menon, K. V.

“…Transmission of congenital clotting factor deficiencies after orthotopic liver transplantation is rare. There are published reports of liver donor‐to‐recipient…”
Get full text

Model for end-stage liver disease (MELD) predicts survival in patients with variceal bleeding by van Ijperen, M., Bambha, K.M., Malinchoc, M., Kremers, W.K., Kim, W.R., Wiesner, R.H., Kamath, P.S.

Get full text

Competition and selection among different HCV strains by Fan, Xiaofeng, Detre, K.M., Belle, S.H., Wei, Y.L., Wiesner, R.H., Charlton, M.R., Schafer, D., Zetterman, R.K., Lake, J.R., Hoofnagle, Jay H., Everhart, James E., Di Bisceglie, Adrian M.

Get full text

Long-Term Comparison of Tacrolimus Versus Cyclosporine in Liver Transplantation by Wiesner, R.H

Get full text

The clinical significance of simultaneous infection with hepatitis G virus in patients with chronic hepatitis C by Brandhagen, D.J, Gross, J.B, Poterucha, J.J, Charlton, M.R, Detmer, J, Kolberg, J, Gossard R.N.P, A.A, Batts, K.P, Kim, W.R, Germer, J.J, Wiesner, R.H, Persing, D.H

“…OBJECTIVES: Hepatitis G virus (HGV) is a recently discovered member of the flavivirus family that has been associated with acute and chronic hepatitis. HGV…”
Get full text

197NF-κB activation in liver allografts correlates with severity of histological disease & fibrosis in recurrent hepatitis C virus disease by Chejfec, G., Gaweco, A.S., Wiesner, R.H., Rustgi, V.K., Porayko, M., Yong, S., Harig, J., McClatchey, K.D., Van Thiel, D.H.

Get full text

F12 Circadian blood pressure pattern is preserved despite the systemic vasodilatation and hyperdynamic cardiac output of end stage liver disease (ESLD) by Taler, S.J., Textor, S.C., Canzanello, V.J., Schwartz, L., Wiesner, R.H., Porayko, M.K., Krom, R.A.F.

Get full text